FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570269285> ?p ?o ?g. }

• W1570269285 abstract "Increasing evidences link T helper 17 (Th17) cells with multiple sclerosis (MS). In this context, interleukin-22 (IL-22), a Th17-linked cytokine, has been implicated in blood brain barrier breakdown and lymphocyte infiltration. Furthermore, polymorphism between MS patients and controls has been recently described in the gene coding for IL-22 binding protein (IL-22BP). Here, we aimed to better characterize IL-22 in the context of MS. IL-22 and IL-22BP expressions were assessed by ELISA and qPCR in the following compartments of MS patients and control subjects: (1) the serum, (2) the cerebrospinal fluid, and (3) immune cells of peripheral blood. Identification of the IL-22 receptor subunit, IL-22R1, was performed by immunohistochemistry and immunofluorescence in human brain tissues and human primary astrocytes. The role of IL-22 on human primary astrocytes was evaluated using 7-AAD and annexin V, markers of cell viability and apoptosis, respectively. In a cohort of 141 MS patients and healthy control (HC) subjects, we found that serum levels of IL-22 were significantly higher in relapsing MS patients than in HC but also remitting and progressive MS patients. Monocytes and monocyte-derived dendritic cells contained an enhanced expression of mRNA coding for IL-22BP as compared to HC. Using immunohistochemistry and confocal microscopy, we found that IL-22 and its receptor were detected on astrocytes of brain tissues from both control subjects and MS patients, although in the latter, the expression was higher around blood vessels and in MS plaques. Cytometry-based functional assays revealed that addition of IL-22 improved the survival of human primary astrocytes. Furthermore, tumor necrosis factor α-treated astrocytes had a better long-term survival capacity upon IL-22 co-treatment. This protective effect of IL-22 seemed to be conferred, at least partially, by a decreased apoptosis. We show that (1) there is a dysregulation in the expression of IL-22 and its antagonist, IL-22BP, in MS patients, (2) IL-22 targets specifically astrocytes in the human brain, and (3) this cytokine confers an increased survival of the latter cells." @default.
• W1570269285 created "2016-06-24" @default.
• W1570269285 creator A5008415173 @default.
• W1570269285 creator A5033576813 @default.
• W1570269285 creator A5035701510 @default.
• W1570269285 creator A5043481685 @default.
• W1570269285 creator A5059317586 @default.
• W1570269285 creator A5075371427 @default.
• W1570269285 creator A5082360565 @default.
• W1570269285 creator A5086195508 @default.
• W1570269285 date "2015-06-16" @default.
• W1570269285 modified "2023-10-16" @default.
• W1570269285 title "Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes" @default.
• W1570269285 cites W1535831265 @default.
• W1570269285 cites W1538907359 @default.
• W1570269285 cites W1576903429 @default.
• W1570269285 cites W1600316672 @default.
• W1570269285 cites W1685219063 @default.
• W1570269285 cites W1926103424 @default.
• W1570269285 cites W1964052073 @default.
• W1570269285 cites W1970626055 @default.
• W1570269285 cites W1972140301 @default.
• W1570269285 cites W1973818929 @default.
• W1570269285 cites W1978342924 @default.
• W1570269285 cites W1978968041 @default.
• W1570269285 cites W1980748156 @default.
• W1570269285 cites W1981126128 @default.
• W1570269285 cites W1987331740 @default.
• W1570269285 cites W1987389251 @default.
• W1570269285 cites W1987729404 @default.
• W1570269285 cites W1998000193 @default.
• W1570269285 cites W2001593633 @default.
• W1570269285 cites W2002987322 @default.
• W1570269285 cites W2004650652 @default.
• W1570269285 cites W2006249161 @default.
• W1570269285 cites W2007121925 @default.
• W1570269285 cites W2008751364 @default.
• W1570269285 cites W2010156984 @default.
• W1570269285 cites W2012199003 @default.
• W1570269285 cites W2025308397 @default.
• W1570269285 cites W2040547343 @default.
• W1570269285 cites W2043573475 @default.
• W1570269285 cites W2049927826 @default.
• W1570269285 cites W2051014917 @default.
• W1570269285 cites W2055912677 @default.
• W1570269285 cites W2059608718 @default.
• W1570269285 cites W2070349522 @default.
• W1570269285 cites W2076889715 @default.
• W1570269285 cites W2079937854 @default.
• W1570269285 cites W2081288407 @default.
• W1570269285 cites W2082317598 @default.
• W1570269285 cites W2092548193 @default.
• W1570269285 cites W2098024163 @default.
• W1570269285 cites W2098241986 @default.
• W1570269285 cites W2103502637 @default.
• W1570269285 cites W2104777875 @default.
• W1570269285 cites W2113291839 @default.
• W1570269285 cites W2116686907 @default.
• W1570269285 cites W2120238028 @default.
• W1570269285 cites W2122545833 @default.
• W1570269285 cites W2127568644 @default.
• W1570269285 cites W2128597204 @default.
• W1570269285 cites W2134496632 @default.
• W1570269285 cites W2139008734 @default.
• W1570269285 cites W2141812010 @default.
• W1570269285 cites W2142577589 @default.
• W1570269285 cites W2143076511 @default.
• W1570269285 cites W2143364414 @default.
• W1570269285 cites W2147335530 @default.
• W1570269285 cites W2164665293 @default.
• W1570269285 cites W2165578318 @default.
• W1570269285 cites W2166475547 @default.
• W1570269285 cites W2172242817 @default.
• W1570269285 cites W4211254511 @default.
• W1570269285 cites W48578805 @default.
• W1570269285 doi "https://doi.org/10.1186/s12974-015-0335-3" @default.
• W1570269285 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4480507" @default.
• W1570269285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26077779" @default.
• W1570269285 hasPublicationYear "2015" @default.
• W1570269285 type Work @default.
• W1570269285 sameAs 1570269285 @default.
• W1570269285 citedByCount "75" @default.
• W1570269285 countsByYear W15702692852015 @default.
• W1570269285 countsByYear W15702692852016 @default.
• W1570269285 countsByYear W15702692852017 @default.
• W1570269285 countsByYear W15702692852018 @default.
• W1570269285 countsByYear W15702692852019 @default.
• W1570269285 countsByYear W15702692852020 @default.
• W1570269285 countsByYear W15702692852021 @default.
• W1570269285 countsByYear W15702692852022 @default.
• W1570269285 countsByYear W15702692852023 @default.
• W1570269285 crossrefType "journal-article" @default.
• W1570269285 hasAuthorship W1570269285A5008415173 @default.
• W1570269285 hasAuthorship W1570269285A5033576813 @default.
• W1570269285 hasAuthorship W1570269285A5035701510 @default.
• W1570269285 hasAuthorship W1570269285A5043481685 @default.
• W1570269285 hasAuthorship W1570269285A5059317586 @default.
• W1570269285 hasAuthorship W1570269285A5075371427 @default.
• W1570269285 hasAuthorship W1570269285A5082360565 @default.
• W1570269285 hasAuthorship W1570269285A5086195508 @default.

• next